Del Rosso James Q, Rosen Theodore, Palceski Dimitry, Rueda Maria Jose
Dr. Del Rosso is with JDR Dermatology Research/Thomas Dermatology in Las Vegas, Nevada.
Dr. Rosen is with Baylor College of Medicine in Houston, Texas.
J Clin Aesthet Dermatol. 2019 Jun;12(6):30-41. Epub 2019 Jun 1.
Antibiotic resistance presents a threat to public health. In dermatology, antibiotics are used extensively for the treatment of acne, sometimes for extended periods. Thus, awareness of antibiotic resistance among dermatology patients is relevant in clinical practice. An online survey assessed antibiotic resistance awareness in adults with acne (n=809) and the parents of adolescents with acne (n=210). More than 80 percent of subjects said that they were "somewhat familiar" or "very familiar" with antibiotic resistance. Overall, 86 percent of the survey respondents identified the correct definition of antibiotic resistance, with parents more likely than their children to choose the proper definition of resistance, as follows: "When antibiotics and/or antibacterials are used for a period of time, the infectious organism adapts to them and becomes immune, resulting in less effective treatment" (95% confidence interval). Among subjects who might have been prescribed antibiotic treatment for their acne, including individuals that reported antibiotic treatment and individuals that were not sure, 76.9 percent reported that they would be very or extremely likely to use effective antibiotic-free options if given the opportunity. More than 90 percent of people with acne and their parents agreed that healthcare providers should do more to educate patients about antibiotics and antibiotic resistance. This survey indicated that patients with acne and their parents think more should be done to educate the public about about the potential risks associated with antibiotic use and the availability of antibiotic-free treatment options. Discussions with patients about antibiotic therapies, antibiotic resistance, and alternative therapies represent areas of opportunity for healthcare providers in dermatology.
抗生素耐药性对公众健康构成威胁。在皮肤科领域,抗生素被广泛用于治疗痤疮,有时疗程还很长。因此,在临床实践中,提高皮肤科患者对抗生素耐药性的认识很有必要。一项在线调查评估了成年痤疮患者(n = 809)以及青少年痤疮患者的父母(n = 210)对抗生素耐药性的认识。超过80%的受试者表示他们对抗生素耐药性“有些熟悉”或“非常熟悉”。总体而言,86%的受访者正确识别了抗生素耐药性的定义,父母比子女更有可能选择正确的耐药性定义,具体如下:“当抗生素和/或抗菌药物使用一段时间后,感染性生物体适应了它们并产生免疫,导致治疗效果降低”(95%置信区间)。在可能因痤疮而接受过抗生素治疗的受试者中,包括报告接受过抗生素治疗的个体以及不确定的个体,76.9%的人表示如果有机会,他们非常或极其有可能使用有效的无抗生素治疗方案。超过90%的痤疮患者及其父母认为医疗保健提供者应该在抗生素及抗生素耐药性方面对患者开展更多教育。这项调查表明,痤疮患者及其父母认为应该开展更多工作,向公众宣传抗生素使用的潜在风险以及无抗生素治疗方案的可获得性。与患者讨论抗生素治疗、抗生素耐药性及替代疗法,是皮肤科医疗保健提供者的机会领域。